Pages that link to "Q34580168"
Jump to navigation
Jump to search
The following pages link to EphA4 receptor tyrosine kinase is a modulator of onset and disease severity of experimental autoimmune encephalomyelitis (EAE) (Q34580168):
Displaying 14 items.
- EphA4 activation of c-Abl mediates synaptic loss and LTP blockade caused by amyloid-β oligomers (Q29347252) (← links)
- Ligand-dependent activation of EphA4 signaling regulates the proteolysis of amyloid precursor protein through a Lyn-mediated pathway (Q31814817) (← links)
- Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis. (Q34109028) (← links)
- Axonally derived matrilin-2 induces proinflammatory responses that exacerbate autoimmune neuroinflammation (Q35140044) (← links)
- Therapeutic targeting of EPH receptors and their ligands (Q38174793) (← links)
- Receptor Tyrosine Kinase and Tyrosine Kinase Inhibitors: New Hope for Success in Multiple Sclerosis Therapy (Q38261946) (← links)
- Axo-Glia Interaction Preceding CNS Myelination Is Regulated by Bidirectional Eph-Ephrin Signaling (Q41836900) (← links)
- A Systems Medicine Approach Reveals Disordered Immune System and Lipid Metabolism in Multiple Sclerosis Patients (Q47342256) (← links)
- Ephrin-A1-EphA4 signaling negatively regulates myelination in the central nervous system. (Q48209163) (← links)
- Protein phosphorylation profiling identifies potential mechanisms for direct immunotoxicity. (Q55066840) (← links)
- EphrinB2 Signalling in Osteoblast Differentiation, Bone Formation and Endochondral Ossification (Q57265483) (← links)
- Reducing EphA4 before disease onset does not affect survival in a mouse model of Amyotrophic Lateral Sclerosis (Q90426015) (← links)
- Decreased signalling of EphA4 improves functional performance and motor neuron survival in the SOD1G93A ALS mouse model (Q90647742) (← links)
- Lowering EphA4 Does Not Ameliorate Disease in a Mouse Model for Severe Spinal Muscular Atrophy (Q91706732) (← links)